AG
Artal Group’s Cyclerion Therapeutics CYCN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-117,643
| Closed | -$271K | – | 22 |
|
|
2024
Q2 | $271K | Sell |
117,643
-21,312
| -15% | -$49K | 0.01% | 105 |
|
|
2024
Q1 | $445K | Hold |
138,955
| – | – | 0.01% | 102 |
|
|
2023
Q4 | $466K | Hold |
138,955
| – | – | 0.02% | 80 |
|
|
2023
Q3 | $475K | Hold |
138,955
| – | – | 0.02% | 84 |
|
|
2023
Q2 | $572K | Sell |
138,955
-2,640,167
| -95% | -$10.9M | 0.02% | 94 |
|
|
2023
Q1 | $1.21M | Hold |
2,779,122
| – | – | 0.07% | 90 |
|
|
2022
Q4 | $1.82M | Hold |
2,779,122
| – | – | 0.1% | 88 |
|
|
2022
Q3 | $2.39M | Hold |
2,779,122
| – | – | 0.1% | 81 |
|
|
2022
Q2 | $1.53M | Hold |
2,779,122
| – | – | 0.08% | 106 |
|
|
2022
Q1 | $3.09M | Hold |
2,779,122
| – | – | 0.13% | 101 |
|
|
2021
Q4 | $4.78M | Hold |
2,779,122
| – | – | 0.13% | 100 |
|
|
2021
Q3 | $8.53M | Hold |
2,779,122
| – | – | 0.19% | 81 |
|
|
2021
Q2 | $10.8M | Buy |
2,779,122
+961,538
| +53% | +$3.75M | 0.22% | 79 |
|
|
2021
Q1 | $5.07M | Hold |
1,817,584
| – | – | 0.09% | 110 |
|
|
2020
Q4 | $5.56M | Hold |
1,817,584
| – | – | 0.12% | 96 |
|
|
2020
Q3 | $11.1M | Sell |
1,817,584
-24,000
| -1% | -$146K | 0.27% | 62 |
|
|
2020
Q2 | $10.9M | Sell |
1,841,584
-20,000
| -1% | -$118K | 0.3% | 54 |
|
|
2020
Q1 | $4.93M | Buy |
1,861,584
+500,000
| +37% | +$1.32M | 0.21% | 64 |
|
|
2019
Q4 | $3.7M | Hold |
1,361,584
| – | – | 0.14% | 72 |
|
|
2019
Q3 | $16.5M | Hold |
1,361,584
| – | – | 0.66% | 25 |
|
|
2019
Q2 | $15.6M | Buy |
+1,361,584
| New | +$15.6M | 0.63% | 28 |
|